Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (11-20 of 382) with videos related to

Pageof 39
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2003
Immunomodulating therapy: new treatment modality in congestive heart failurePål Aukrust, Jan Kristian Damås, Lars Gullestad
Current Opinion in Organ Transplantation|May 3, 2017
Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?Einar Gude, Lars Gullestad, Arne K Andreassen
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Cytokines as new treatment targets in chronic heart failureJan Kristian Damås, Lars Gullestad, Pål Aukrust
BMC Sports Science, Medicine & Rehabilitation|June 11, 2020
Effect of high-intensity interval training in young heart transplant recipients: results from two randomized controlled trialsKari Nytrøen, Katrine Rolid, Marianne Yardley, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 13, 2021
Reply: Safety of intravenous iron in heart transplant patients: Comment to paper by Brautaset Englund et alKaspar Broch, Kristine Victoria Brautaset Englund, Lars Gullestad
Journal of the American College of Cardiology|August 29, 2009
Testosterone: a novel therapeutic approach in chronic heart failure?Pål Aukrust, Thor Ueland, Lars Gullestad, et al.
Heart & Lung : the Journal of Critical Care|August 2, 2003
A descriptive study of early nonspecific chest pain after PTCA: important area for the acute health care personnelMarit Ronnevig, Elisabeth Bjorsvik, Lars Gullestad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Therapeutic potential of anticytokine therapy in congestive heart failurePal Aukrust, Arne Yndestad, Jan K Damås, et al.
Autoimmunity Reviews|April 28, 2004
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulinPål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
American Journal of Respiratory and Critical Care Medicine|February 28, 2022
Reply to Lalonde <i>et al</i>.: Why Would Physiologic Support with Continuous Positive Airway Pressure Not Improve Outcomes in Patients with Atrial Fibrillation with Sleep Apnea?Gunn Marit Traaen, Harriet Akre, Jan Pål Loennechen, et al.
Pageof 39

Showing results (11-20 of 382) with videos related to

Sort By:
Pageof 39
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2003
Immunomodulating therapy: new treatment modality in congestive heart failurePål Aukrust, Jan Kristian Damås, Lars Gullestad
Current Opinion in Organ Transplantation|May 3, 2017
Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?Einar Gude, Lars Gullestad, Arne K Andreassen
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Cytokines as new treatment targets in chronic heart failureJan Kristian Damås, Lars Gullestad, Pål Aukrust
BMC Sports Science, Medicine & Rehabilitation|June 11, 2020
Effect of high-intensity interval training in young heart transplant recipients: results from two randomized controlled trialsKari Nytrøen, Katrine Rolid, Marianne Yardley, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 13, 2021
Reply: Safety of intravenous iron in heart transplant patients: Comment to paper by Brautaset Englund et alKaspar Broch, Kristine Victoria Brautaset Englund, Lars Gullestad
Journal of the American College of Cardiology|August 29, 2009
Testosterone: a novel therapeutic approach in chronic heart failure?Pål Aukrust, Thor Ueland, Lars Gullestad, et al.
Heart & Lung : the Journal of Critical Care|August 2, 2003
A descriptive study of early nonspecific chest pain after PTCA: important area for the acute health care personnelMarit Ronnevig, Elisabeth Bjorsvik, Lars Gullestad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Therapeutic potential of anticytokine therapy in congestive heart failurePal Aukrust, Arne Yndestad, Jan K Damås, et al.
Autoimmunity Reviews|April 28, 2004
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulinPål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
American Journal of Respiratory and Critical Care Medicine|February 28, 2022
Reply to Lalonde <i>et al</i>.: Why Would Physiologic Support with Continuous Positive Airway Pressure Not Improve Outcomes in Patients with Atrial Fibrillation with Sleep Apnea?Gunn Marit Traaen, Harriet Akre, Jan Pål Loennechen, et al.
Pageof 39